Cargando…

Zonisamide Changes Unilateral Cortical Excitability in Focal Epilepsy Patients

BACKGROUND AND PURPOSE: To evaluate changes in cortical excitability induced by zonisamide (ZNS) in focal epilepsy patients. METHODS: Twenty-four drug-naїve focal epilepsy patients (15 males; overall mean age 29.8 years) were enrolled. The transcranial magnetic stimulation parameters obtained using...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joo, Eun Yeon, Kim, Hye-Jung, Lim, Yang-Hee, Ji, Ki-Hwan, Hong, Seung Bong
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3024523/ https://www.ncbi.nlm.nih.gov/pubmed/21264199 http://dx.doi.org/10.3988/jcn.2010.6.4.189

Ejemplares similares

Lateralizing Cortical Excitability in Drug Naïve Patients with Generalized or Focal Epilepsy
por: Lee, Jung Hwa, et al.
Publicado: (2015)

Surgical outcome and prognostic factors in epilepsy patients with MR-negative focal cortical dysplasia
por: Seong, Min Jae, et al.
Publicado: (2021)

Zonisamide in the management of epilepsy in the elderly
por: Romigi, Andrea, et al.
Publicado: (2015)

Tracking cortical excitability dynamics with transcranial magnetic stimulation in focal epilepsy
por: Helling, Robert M., et al.
Publicado: (2022)

Zonisamide Efficacy as Adjunctive Therapy in Children With Refractory Epilepsy
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013)

Safety and Efficacy of Zonisamide in Patients with Epilepsy: A Post-Marketing Surveillance Study
por: Lee, Hye Jin, et al.
Publicado: (2015)

Long-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients
por: Park, Sung-Pa, et al.
Publicado: (2007)

Is Focal Cortical Dysplasia/Epilepsy Caused by Somatic MTOR Mutations Always a Unilateral Disorder?
por: Guerrini, Renzo, et al.
Publicado: (2020)

The Role of Focal Epilepsy Features in Defining SCN1A Mutation-positive Dravet Syndrome as Generalized and Focal Epilepsy
por: Ko, Young Jun, et al.
Publicado: (2021)

Comparative Efficacy of Zonisamide and Pregabalin as an Adjunctive Therapy in Children with Refractory Epilepsy
por: TAGHDIRI, Mohammad Mahdi, et al.
Publicado: (2015)

Focal Cortical Dysplasia and Epilepsy Surgery
por: Lee, Sang Kun, et al.
Publicado: (2013)

Cortical stimulation in pharmacoresistant focal epilepsies
por: Ellrich, Jens
Publicado: (2020)

Seizure Duration Determined by Subdural Electrode Recordings in Adult Patients with Intractable Focal Epilepsy
por: Kim, Daeyoung, et al.
Publicado: (2011)

Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature
por: Zaccara, Gaetano, et al.
Publicado: (2009)

Zonisamide‐responsive myoclonus in SEMA6B‐associated progressive myoclonic epilepsy
por: Herzog, Rebecca, et al.
Publicado: (2021)

Intracranial Cortical Calcifications in a Focal Epilepsy Patient with Pseudohypoparathyroidism
por: Kim, Ye Sel, et al.
Publicado: (2016)

Increased facial asymmetry in focal epilepsies associated with unilateral lesions
por: Balestrini, Simona, et al.
Publicado: (2021)

Cortical excitability correlates with seizure control and epilepsy duration in chronic epilepsy
por: Pawley, Adam D., et al.
Publicado: (2017)

Zonisamide Therapy Reduces Metabolic Consequences and Diminishes Nonalcoholic Fatty Liver Disease in Patients with Epilepsy
por: Huang, Chi-Ren, et al.
Publicado: (2021)

Distal renal tubular acidosis and lethargy associated with zonisamide treatment in a dog with idiopathic epilepsy
por: Itoi, Takamasa, et al.
Publicado: (2022)

Evaluation of antiseizure medications including zonisamide in feline idiopathic epilepsy at a referral hospital in Japan
por: Yoshida, Shino, et al.
Publicado: (2023)

Antiepileptic Drug Withdrawal after Surgery in Children with Focal Cortical Dysplasia: Seizure Recurrence and Its Predictors
por: Choi, Sun Ah, et al.
Publicado: (2019)

Cutting-Edge Classification of Focal Cortical Dysplasia for Epilepsy Surgery
por: Vossler, David G.
Publicado: (2021)

Focal Cortical Lesions Induce Bidirectional Changes in the Excitability of Fast Spiking and Non Fast Spiking Cortical Interneurons
por: Imbrosci, Barbara, et al.
Publicado: (2014)

Impact of Pregnancy on Zonisamide Pharmacokinetics in Rabbits
por: Matar, Kamal M.
Publicado: (2013)

Repositioning again of zonisamide for nerve regeneration
por: Ohno, Kinji, et al.
Publicado: (2016)

Zonisamide-induced acute kidney injury
por: Dixit, Deepali, et al.
Publicado: (2015)

Efficacy of Zonisamide in Migraineurs with Nonresponse to Topiramate
por: Chung, Jin-Young, et al.
Publicado: (2014)

Zonisamide-Induced Hallucinations: An Anticonvulsant’s Psychosis
por: Al Armashi, Abdul Rahman, et al.
Publicado: (2021)

Focal Myositis of Unilateral Leg
por: Jun, Jin, et al.
Publicado: (2011)

Cognitive Profile of Zonisamide and Valproic Acid in the Treatment of Idiopathic Generalized Epilepsy: A Comparative Observational Study
por: Ramirez-García, Teresa, et al.
Publicado: (2016)

Seven tesla MRI improves detection of focal cortical dysplasia in patients with refractory focal epilepsy
por: Veersema, Tim J., et al.
Publicado: (2017)

Asymmetric Gray Matter Volume Changes Associated with Epilepsy Duration and Seizure Frequency in Temporal-Lobe-Epilepsy Patients with Favorable Surgical Outcome
por: Kim, Jeong Sik, et al.
Publicado: (2016)

Limited efficacy of zonisamide in the treatment of refractory infantile spasms
por: Hussain, Shaun A., et al.
Publicado: (2020)

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
por: Marson, Anthony, et al.
Publicado: (2021)

Erratum to: Asymmetric Gray Matter Volume Changes Associated with Epilepsy Duration and Seizure Frequency in Temporal-Lobe-Epilepsy Patients with Favorable Surgical Outcome
por: Kim, Jeong Sik, et al.
Publicado: (2016)

Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy
por: Møller, Rikke S., et al.
Publicado: (2016)

Clinical Experience with Perampanel in Intractable Focal Epilepsy Over 12 Months of Follow-Up
por: Kim, Soo Yeon, et al.
Publicado: (2018)

Zonisamide is effective in the preventive therapy of chronic migraine
por: Belvis, R, et al.
Publicado: (2013)

Probable drug-induced lupus erythematosus by zonisamide
por: Safadi, Mohannad G., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_84lf98a8o4pgs7olkd4q010bmd